These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3795354)

  • 1. Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimens.
    Dexeus FH; Logothetis CJ; Samuels ML; Ayala AG; Hossan E
    J Urol; 1987 Jan; 137(1):122-5. PubMed ID: 3795354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases.
    Logothetis CJ; Samuels ML; Ogden S; Dexeus FH; Swanson D; Johnson DE; von Eschenbach A
    J Urol; 1985 Sep; 134(3):460-4. PubMed ID: 2993671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide].
    Takigawa H; Odachi M; Kagawa S; Kurokawa K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complete remission of brain metastasis of bladder cancer treated by M-VAC therapy].
    Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K
    Hinyokika Kiyo; 1989 Feb; 35(2):333-5. PubMed ID: 2735244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.
    Logothetis CJ; Dexeus FH; Chong C; Sella A; Ayala AG; Ro JY; Pilat S
    J Urol; 1989 Jan; 141(1):33-7. PubMed ID: 2908950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitional cell carcinoma of the prostate: response to treatment with cisplatinum and cyclophosphamide.
    Alexander SJ; Lee SS; Bekhrad A
    J Urol; 1984 May; 131(5):975-7. PubMed ID: 6538603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N; Weiselberg LR
    J Urol; 1988 Mar; 139(3):461-9. PubMed ID: 3343727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
    Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report.
    Stewart DJ; Dahrouge S
    Am J Clin Oncol; 1997 Aug; 20(4):381-2. PubMed ID: 9256894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged remission in a patient with transitional cell carcinoma of the bladder developing brain metastases after systemic chemotherapy: a case report.
    Jankevicius F; Sruogis A; Ulys A; Zykus A; Sumauskas R
    Tumori; 2004; 90(4):420-1. PubMed ID: 15510987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.
    Torti FM; Harker WG
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S1-4. PubMed ID: 6357518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: a phase-II study.
    Popov I; Jelíc S; Radosavljevíc D; Nikolíc-Tomasevíc Z
    Eur Urol; 2001 Sep; 40(3):324-9. PubMed ID: 11684850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
    Al-Sarraf M; Frank J; Smith JA; O'Bryan RM; Costanzi JJ; Stephens RL; Caraveo J; Crawford ED
    Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial.
    Troner M; Birch R; Omura GA; Williams S
    J Urol; 1987 Apr; 137(4):660-2. PubMed ID: 3550148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intensity systemic therapy of metastatic bladder cancer.
    Hrushesky WJ; Roemeling RV; Wood PA; Langevin TR; Lange P; Farley E
    J Clin Oncol; 1987 Mar; 5(3):450-5. PubMed ID: 3819809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant intra-arterial chemotherapy in the treatment of advanced transitional cell carcinoma of the bladder: results and followup.
    Galetti TP; Pontes JE; Montie J; Medendorp SV; Bukowski R
    J Urol; 1989 Nov; 142(5):1211-4; discussion 1214-5. PubMed ID: 2810495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV chemotherapy for advanced transitional cell carcinoma.
    Jeffery GM; Mead GM
    Br J Cancer; 1992 Sep; 66(3):542-6. PubMed ID: 1520591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of carcinoma of renal pelvis: preliminary report.
    Trindade A; Samuels ML; Logothetis CJ
    Urology; 1981 Jul; 18(1):54-9. PubMed ID: 6894814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical metastases from transitional vesical carcinoma.
    Peterson NE
    Urology; 1989 Sep; 34(3):148-51. PubMed ID: 2675455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.